![](https://be.mit.edu/sites/default/files/styles/faculty_profile__274x274_/public/MIT-ALS-Epigenome-01_0.jpg?itok=ZPZxV1NU)
Epigenomic analysis sheds light on risk factors for ALS
Thursday, May 2, 2024
In a study of cells from nearly 400 ALS patients, researchers identified genomic regions with chemical modifications linked to disease progression.
In a study of cells from nearly 400 ALS patients, researchers identified genomic regions with chemical modifications linked to disease progression.